- Home
- RBBN vs ARVN Comparison
RBBN vs ARVN Comparison
Compare RBBN & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBBN
- ARVN
- Stock Information
- Founded
- RBBN 1997
- ARVN 2015
- Country
- RBBN United States
- ARVN United States
- Employees
- RBBN N/A
- ARVN N/A
- Industry
- RBBN EDP Services
- ARVN Biotechnology: Pharmaceutical Preparations
- Sector
- RBBN Technology
- ARVN Health Care
- Exchange
- RBBN Nasdaq
- ARVN Nasdaq
- Market Cap
- RBBN 671.1M
- ARVN 676.2M
- IPO Year
- RBBN 2000
- ARVN 2018
- Fundamental
- Price
- RBBN $2.82
- ARVN $12.82
- Analyst Decision
- RBBN Strong Buy
- ARVN Buy
- Analyst Count
- RBBN 4
- ARVN 23
- Target Price
- RBBN $6.00
- ARVN $17.80
- AVG Volume (30 Days)
- RBBN 876.2K
- ARVN 3.1M
- Earning Date
- RBBN 10-22-2025
- ARVN 11-05-2025
- Dividend Yield
- RBBN N/A
- ARVN N/A
- EPS Growth
- RBBN N/A
- ARVN N/A
- EPS
- RBBN N/A
- ARVN N/A
- Revenue
- RBBN $868,592,000.00
- ARVN $312,300,000.00
- Revenue This Year
- RBBN $5.02
- ARVN N/A
- Revenue Next Year
- RBBN $5.74
- ARVN N/A
- P/E Ratio
- RBBN N/A
- ARVN N/A
- Revenue Growth
- RBBN 7.38
- ARVN 93.86
- 52 Week Low
- RBBN $2.78
- ARVN $5.90
- 52 Week High
- RBBN $5.38
- ARVN $27.00
- Technical
- Relative Strength Index (RSI)
- RBBN 27.22
- ARVN 74.49
- Support Level
- RBBN $2.94
- ARVN $10.00
- Resistance Level
- RBBN $3.14
- ARVN $11.51
- Average True Range (ATR)
- RBBN 0.12
- ARVN 0.73
- MACD
- RBBN -0.03
- ARVN 0.16
- Stochastic Oscillator
- RBBN 5.19
- ARVN 71.92
About RBBN Ribbon Communications Inc.
Ribbon Communications Inc provides network solutions to service providers and enterprises. The company enables service providers and enterprises to modernize their communications networks and provide secure real-time communications solutions to their customers and employees. The company has two separate lines of business; the Cloud and Edge segment, and the IP Optical Networks segment. The majority of the revenue for the company is generated from its Cloud and Edge segment that provides secure and reliable software and hardware products, solutions, and services for VoIP communications, Voice Over LTE among others to service providers and enterprise customers. The company generates majority of its revenue from United States.
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.